Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Young

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|February 15, 2016
Eribulin in soft-tissue sarcomaRobin J Young, Penella J Woll
Memo|December 19, 2017
Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical updateRobin J Young, Penella J Woll
Future Oncology (London, England)|May 8, 2013
Zoledronic acid to prevent and treat cancer metastasis: new prospects for an old drugRobin J Young, Robert E Coleman
Oncotargets and Therapy|March 1, 2017
Efficacy of eribulin in breast cancer: a short report on the emerging new dataGelareh Eslamian, Caroline Wilson, Robin J Young
Microcirculation (New York, N.Y. : 1994)|November 15, 2011
Anti-angiogenic therapy: concept to clinicRobin J Young, Malcolm W R Reed
Cancer Drug Resistance (Alhambra, Calif.)|January 13, 2025
CIRCUS: CIRCUlating tumour cells in soft tissue Sarcoma - a short reportRobin J Young, Joanna E Chowdry, Denis Cochonneau, et al.
Journal of Clinical Pathology|August 29, 2024
Sinonasal alveolar rhabdomyosarcoma with <i>PAX3::NCOA1</i> fusion expressing SOX10 and with nodal metastases: a double diagnostic pitfallHannah Crane, Robin J Young, Malee S Fernando, et al.
Experimental and Molecular Pathology|July 2, 2014
Angiogenic growth factor expression in benign and malignant vascular tumoursRobin J Young, Malee Fernando, David Hughes, et al.
The Lancet. Oncology|June 12, 2010
AngiosarcomaRobin J Young, Nicola J Brown, Malcolm W Reed, et al.
BMC Cancer|March 20, 2025
Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trialRobin J Young, Amanda Kirkham, Joshua Savage, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|February 15, 2016
Eribulin in soft-tissue sarcomaRobin J Young, Penella J Woll
Memo|December 19, 2017
Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical updateRobin J Young, Penella J Woll
Future Oncology (London, England)|May 8, 2013
Zoledronic acid to prevent and treat cancer metastasis: new prospects for an old drugRobin J Young, Robert E Coleman
Oncotargets and Therapy|March 1, 2017
Efficacy of eribulin in breast cancer: a short report on the emerging new dataGelareh Eslamian, Caroline Wilson, Robin J Young
Microcirculation (New York, N.Y. : 1994)|November 15, 2011
Anti-angiogenic therapy: concept to clinicRobin J Young, Malcolm W R Reed
Cancer Drug Resistance (Alhambra, Calif.)|January 13, 2025
CIRCUS: CIRCUlating tumour cells in soft tissue Sarcoma - a short reportRobin J Young, Joanna E Chowdry, Denis Cochonneau, et al.
Journal of Clinical Pathology|August 29, 2024
Sinonasal alveolar rhabdomyosarcoma with <i>PAX3::NCOA1</i> fusion expressing SOX10 and with nodal metastases: a double diagnostic pitfallHannah Crane, Robin J Young, Malee S Fernando, et al.
Experimental and Molecular Pathology|July 2, 2014
Angiogenic growth factor expression in benign and malignant vascular tumoursRobin J Young, Malee Fernando, David Hughes, et al.
The Lancet. Oncology|June 12, 2010
AngiosarcomaRobin J Young, Nicola J Brown, Malcolm W Reed, et al.
BMC Cancer|March 20, 2025
Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trialRobin J Young, Amanda Kirkham, Joshua Savage, et al.
Pageof 2